Does using animation in pharma ads trivialize warnings?

Emily Marchak 03/18/16 - 8:13 pm

Mr. Mucus is meant to be gross. The snot monster and antihero should make cold sufferers reach for Mucinex. Same goes for the cute, overactive, texting bladder in Myrbetriq’s ad. They’re memorable, but do consumers miss critical information when the message comes from cartoon characters.

The U.S. Food and Drug Administration (FDA) wants to know.

Animation has been known to increase brand recall and association. But what happens when animation is used in pharmaceutical drug marketing campaigns?

The FDA will be studying the use of animation in pharmaceutical drug ads to better understand how these visuals affect consumer behavior. The main purpose of this study is to observe whether the use of animation has a detrimental effect on consumers’ recollection of the important safety information and drug side effects.

In order to gather these insights, the FDA will be performing two studies, with the employment of an advertising firm. The first will test creative that features human actors. The second will involve different levels of animation, including live actors transforming into animated figures or the use of animations to represent the illness, medication or patient.

What brands are currently using animation? Take a look.

1. Abilify

2. Jublia

3. Mucinex

4. Myrbetriq

5. Xifaxan

What are your thoughts? Let us know in the comments below. 

Blog Category: Branding Healthcare

Why Brogan?

We are true partners. With a proven track record of delivering strategic marketing expertise, award-winning creative and real-time, data-driven media, we go above and beyond for our clients to get results. We even guarantee you’ll be delighted.